Abstract

The present invention relates generally to cell therapy, immunology, cancer vaccine and the treatment of cancer diseases. In particular, it relates to novel immunogenic formulations of cell lysates from heat-shock conditioned tumor cell populations combined with a immunologically effective amount of adjuvant, for treating cancer in a subject and methods thereof.